Nirma's acquisition of majority stake in Glenmark Life Scien

Glenmark Pharmaceuticals has entered into a share purchase agreement with Nirma Limited to divest a 75% stake in Glenmark Lifesciences at a price of Rs 615 per share.

Related Keywords

Mohol , Maharashtra , India , Vietnam , Republic Of , Brazil , Apis , Northern Samar , Philippines , Dahej , Gujarat , Mexico , Ankleshwar , Ahmedabad , Chincholi , Karnataka , China , Solapur , Abdulkader Puranwala , Poornima Vardhan , Dhiren Patel , Rohan John , Glenmark Pharma , Salil Kallianpur , Tushar Manudhane , Stericon Pharma , Glenn Saldanha , Taponeel Mukherjee , Glenmark Lifesciences , Aculife Healthcare Pvt Ltd , Contract Development , Nirma Group , Manufacturing Organization , Stericon Pharma Pvt Ltd , Glenmark Life Sciences , Research Analyst At Motilal Oswal Financial Services , Khaitan Co , Glenmark Pharmaceuticals , Indian Contract Development , Nirma Limited , Active Pharmaceutical Ingredient , Invested Capital , Compound Annual Growth Rate , Stericon Pharma Pvt , Aculife Healthcare , Gaseous Anesthesia , Managing Director , Life Sciences Limited , Glenmark Life , Research Analyst , Motilal Oswal Financial Services Limited , Production Linked Incentives , Earnings Before Interest , Nirma ,